Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab
Clinical trial NCT04377555 · COMPLETED
Trial details
- NCT number
- NCT04377555
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2022-12-15
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.